All Pathways
Internal MedicineManagement

Hypertension Management (ACC/AHA 2017)

Hypertension Management (ACC/AHA 2017): Blood Pressure Measurement → BP Classification → Normal BP (<120/80).

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Blood Pressure Measurement

    Average of ≥2 readings on ≥2 occasions

    1. Decision

      BP Classification

      Classify based on systolic/diastolic readings

      • Normal: <120/<80 mmHg
      • Elevated: 120-129/<80 mmHg
      • Stage 1 HTN: 130-139 or 80-89 mmHg
      • Stage 2 HTN: ≥140 or ≥90 mmHg
      1. Outcome

        Normal BP (<120/80)

        Promote healthy lifestyle, reassess annually

      2. Action

        Elevated BP (120-129/<80)

        Nonpharmacologic therapy

        • Weight loss if overweight
        • DASH diet
        • Sodium reduction <1500mg/day
        • Physical activity 90-150 min/week
        • Limit alcohol
        1. Action

          ASCVD Risk <10%

          Lifestyle modification, reassess in 3-6 months

          • Nonpharmacologic therapy alone initially
          • If BP still elevated at 3-6 months, add medication
          • Consider medication if compelling indication
          1. Action

            First-Line Antihypertensive Agents

            Choose based on compelling indications

            • Thiazide diuretics (chlorthalidone preferred)
            • ACE inhibitors (if DM, CKD, HF, post-MI)
            • ARBs (alternative to ACE-I)
            • Calcium channel blockers (DHP preferred)
            • Avoid: ACE-I + ARB combination
            1. Action

              Compelling Indications

              Specific drug classes recommended

              • CKD: ACE-I or ARB
              • Diabetes: ACE-I or ARB
              • Heart Failure: ACE-I/ARB + BB + diuretic
              • Post-MI: BB + ACE-I
              • Recurrent stroke: Thiazide + ACE-I
              • Stable CAD: BB, CCB, ACE-I
              1. Action

                Monthly Follow-Up

                Titrate until goal achieved

                • Goal: <130/80 for most patients
                • Increase dose or add agent monthly if not at goal
                • If 3 agents needed, add spironolactone
                • Consider specialist referral if resistant
                1. Outcome

                  BP Goal Achieved (<130/80)

                  Continue therapy, follow-up every 3-6 months

                2. Warning

                  Resistant Hypertension

                  BP above goal on ≥3 agents including diuretic

                  • Confirm true resistance (adherence, technique)
                  • Screen for secondary causes
                  • Consider specialist referral
                  • Add spironolactone 25-50mg
      3. Decision

        Stage 1 HTN (130-139/80-89)

        Assess 10-year ASCVD risk

        • Use ACC/AHA ASCVD Risk Calculator
        • Consider clinical ASCVD, DM, CKD
        • Risk ≥10% = high risk
        1. Action

          ASCVD Risk ≥10% or Clinical CVD/DM/CKD

          Lifestyle + pharmacotherapy

          • Start single first-line agent
          • Titrate to goal <130/80
          • Follow up in 1 month
      4. Action

        Stage 2 HTN (≥140/90)

        Initiate pharmacotherapy + lifestyle

        • Start with 2 first-line agents
        • Consider single-pill combination
        • BP goal <130/80 for most patients

Guideline Source

2017 ACC/AHA Guideline for Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address pediatric hypertension
  • Does not cover hypertensive emergency (see separate algorithm)
  • Drug dosing not included - refer to institutional protocols
  • Secondary hypertension workup requires specialist evaluation
  • Pregnancy-related hypertension requires OB consultation

Contraindicated Populations

pediatricpregnancy

Applicable Regions

USEU

EU: ESC/ESH 2018 uses slightly different thresholds

US: Based on ACC/AHA 2017 guidelines with BP threshold 130/80

Version 1Next review: 2028-01-01

Frequently Asked Questions

What is the Hypertension Management (ACC/AHA 2017)?

The Hypertension Management (ACC/AHA 2017) is a management clinical algorithm for Internal Medicine. It provides a structured decision tree to guide clinical decision-making, based on 2017 ACC/AHA Guideline for Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

What guideline is the Hypertension Management (ACC/AHA 2017) based on?

This algorithm is based on 2017 ACC/AHA Guideline for Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (DOI: 10.1161/HYP.0000000000000065).

What are the limitations of the Hypertension Management (ACC/AHA 2017)?

Known limitations include: Does not address pediatric hypertension; Does not cover hypertensive emergency (see separate algorithm); Drug dosing not included - refer to institutional protocols; Secondary hypertension workup requires specialist evaluation; Pregnancy-related hypertension requires OB consultation. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Hypertension Management (ACC/AHA 2017) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free